Adam Stoten
Director/Board Member at Vaccitech (UK) Ltd.
Network origin in Adam Stoten first degree
Entity | Entity type | Industry | |
---|---|---|---|
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom.
10
| Holding Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Adam Stoten via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
St. Michael's Hospital
St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Duke Clinical Research Institute
Duke Clinical Research Institute Pharmaceuticals: OtherHealth Technology Duke Clinical Research Institute manufactures medical and botanical products. It offers specialized patient databases and clinical and operational expertise. The firm accelerates the development of therapies, diagnostics, and medical devices to humans. The company was founded in 1969 and is headquartered in Durham, NC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal | |
PHARMING GROUP N.V. | Pharmaceuticals: Major | Director of Finance/CFO | |
OREXO AB | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Toronto | College/University | Doctorate Degree | |
University of Western Ontario | College/University | Undergraduate Degree | |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Director of Finance/CFO | |
ABLYNX | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Royal Institute of Technology | College/University | Graduate Degree | |
The University of Western Australia | College/University | Undergraduate Degree | |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Royal College of Physicians & Surgeons of Canada
Royal College of Physicians & Surgeons of Canada Other Consumer ServicesConsumer Services The Royal College of Physicians & Surgeons of Canada operates a college for medical professionals. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Andrew Padmos. | Other Consumer Services | Corporate Officer/Principal | |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Duke University Medical Center | College/University | Corporate Officer/Principal | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Wellesley Hospital | Corporate Officer/Principal | ||
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Scripps Clinic & Research Foundation | Corporate Officer/Principal | ||
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
The Royal Australasian College of Physicians | Corporate Officer/Principal | ||
Wellstat Biologics Corp.
Wellstat Biologics Corp. Pharmaceuticals: MajorHealth Technology Wellstat Biologics Corp. is a private company that focuses on the development and commercialization of biological agents. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Graduate Degree | |
ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImQuest BioSciences, Inc.
ImQuest BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services ImQuest BioSciences, Inc. provides preclinical contract research and development services. It offers virology, toxicology, product formulation, oncology services. The company was founded by Daniel R. Caffoe and Robert Buckheit Jr. in 2004 and is headquartered in Frederick, MD. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
VTV THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Hy. Duke & Son Ltd.
Hy. Duke & Son Ltd. Specialty StoresRetail Trade Hy. The private company is based in Dorchester, UK, and their fine art salerooms are centrally located in the county town, close to the main Dorchester South railway station. Duke & Son Ltd. is a British company that deals with militaria and sporting goods, as well as silver and objects of vertu. The company also provides valuations for inheritance tax assessment. The company was founded in 1999, and Lee Young has been the CEO of the company since 2017. | Specialty Stores | Corporate Officer/Principal | |
Leweston School | Director/Board Member | ||
ALTIMMUNE, INC. | Biotechnology | Chief Executive Officer | |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Theolytics Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Macrophox Ltd.
Macrophox Ltd. BiotechnologyHealth Technology Macrophox Ltd. engages in the provision of research and experimental development on biotechnology. The company was founded on March 12, 2018 and is headquartered in Woodstock, The United Kingdom. | Biotechnology | Director/Board Member | |
Pepgen Ltd.
Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Director/Board Member | |
BULLFROG AI HOLDINGS, INC. | Packaged Software | Director/Board Member | |
BARINTHUS BIOTHERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chairman Founder Founder Chief Tech/Sci/R&D Officer Director/Board Member Chief Operating Officer Director/Board Member | |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | Pharmaceuticals: Major | Director/Board Member | |
Velia, Inc.
Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023. | Packaged Software | Chief Executive Officer | |
Gravitas Therapeutics, Inc.
Gravitas Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gravitas Therapeutics, Inc. is an American clinical-stage company that provides antifungal treatment for aspergillus mold infections. The CEO of the private company is Thomas E. Smart. | Miscellaneous Commercial Services | Director/Board Member | |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Actio Biosciences, Inc. is an American precision medicine company that focuses on developing new therapeutics for rare and common diseases by targeting shared genetics. Actio Biosciences was founded in October 2021 and is based in an undisclosed location. The company applies its expertise in genetics, drug discovery, and data sciences to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward potent and precisely targeted therapeutics. The company is led by leaders in genetics and drug development and backed by top healthcare investors. | Pharmaceuticals: Major | Founder | |
METACRINE, INC. | Biotechnology | Director/Board Member |
Statistics
International
United States | 26 |
United Kingdom | 12 |
Canada | 6 |
Sweden | 5 |
Australia | 4 |
Sectoral
Health Technology | 25 |
Consumer Services | 11 |
Commercial Services | 6 |
Technology Services | 4 |
Health Services | 2 |
Operational
Director/Board Member | 101 |
Corporate Officer/Principal | 31 |
Chairman | 27 |
Independent Dir/Board Member | 25 |
Chief Executive Officer | 14 |
Most connected contacts
Insiders | |
---|---|
Edwin Moses | 35 |
Karen Dawes | 22 |
John McHutchison | 14 |
Anne Phillips | 14 |
Paul Carter | 12 |
William Enright | 12 |
Steven N. Chatfield | 11 |
Sarah Gordon-Wild | 11 |
Andrew James Mclean | 10 |
Antonin Rollet de Fougerolles | 9 |
Thomas Evans | 9 |
Per Lundin | 8 |
Robin Wright | 8 |
Martin Andrews | 7 |
Alex Hammacher | 6 |
- Stock Market
- Insiders
- Adam Stoten
- Company connections